ChromaDex adds top Alzheimer’s Disease researcer to its science advisory board

Today’s NR news, mentioned by Dave in the comments:

ChromaDex added Rudolph Tanzi, the Vice-Chair of Neurology and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital and a professor of neurology at Harvard Medical School. He gave a TEDx Talk early this year where he predicted that Alzheimer’s Disease will be beaten by 2025.

* * * * *

I’d like to know why ChromaDex’s stock is still only $3.90 a share* given that the CEO says it will release its impressive human trial results this summer. No detailed results from Elysium either despite having its 120 human trial data for about a year.

* I don’t own Chromadex stock – just enjoying the show.

Advertisements
This entry was posted in health, Health Pills and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s